Semin Reprod Med 2000; 18(4): 401-406
DOI: 10.1055/s-2000-13730
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Immunodystrophism: Evidence for a Novel Alloimmune Hypothesis for Recurrent Pregnancy Loss Involving Th1-Type Immunity to Trophoblast

Joseph A. Hill III1 , Bum Chae Choi2
  • 1The Center for Reproductive Medicine and the Fearing Research Laboratory, Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts
  • 2Recurrent Pregnancy Loss Center, Creation and Love Women's Hospital, Kwang-ju, Korea
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Preview

ABSTRACT

Pregnancy loss is the most common complication of pregnancy. Recurrent pregnancy loss occurs in approximately 1% of pregnant women. Many immunologic theories have been proposed but have not withstood rigorous analysis. A novel alloimmune hypothesis involving T helper (Th) 1-type immunity to trophoblast is the latest theory proposed for recurrent pregnancy loss. The basic hypothesis is, in the decidua there are myriad of antigen presenting cells and other immune response cells. In response to trophoblast invasion, these cells may become activated. A by-product of this activation is the secretion by these cells of either a predominant Th1 or Th2 cytokine profile. In cases where a Th1 cytokine profile predominates, chiefly, interferon-gamma, tumor necrosis factor, or interleukin-12, these cytokines may directly or indirectly be detrimental to early placental cell differentiation and growth and toxic to embryo development. Further evidence for this novel hypothesis comes from recent findings of a genetic predisposition for a vigorous Th1 cytokine response in these women due to a polymorphism in the IL1B promoter region. Further studies are needed to substantiate definitive causative links between Th1-immunity to trophoblast and recurrent pregnancy loss. Clinical trials are also needed to determine the best therapy for this disorder.

REFERENCES